1 "주요 우울증 환자에서의 Mirtazapine의 항우울 효과" 11 (11): 126-135, 2000
2 "World Health Organization. International Statistical Classification of Diseases and Related Health Problems" -10, geneva1992.
3 "Treatment of coexisting depression and anxiety: The Depression Research in European Society(DEPRES) Survey" 5 : 9-11, 19
4 "The selective alpha2-adrenoceptor an-tagonist mirtazapine (Org 3770) enhances noradrenergic and 5-HT1A-mediated serotonergic neurotransmission" 4 (4): 29-38, 1995
5 "The pharmacology of putative early-onset antidepressant strategies." 13 (13): 57-66, 2003
6 "The efects of mirtazapine on central noradrenergic and serotonergic neurotransmision." 10 (10): 19-24, 1995
7 "The alpha2 selective adrenoceptor antagonist Org 3770 (mirtazapine, Remeron) en-hances noradrenergic and serotonergic transmission" 10 : 107-119, 195
8 "Starting SRI antidepressant therapy: its efects on tricyclic antidepressant and benzodiazepine prescribing" 164 : 509-, 1996
9 "Short-term cotherapy with clonazepam and fluoxetine sleep dis-turbance and core symptoms of depression." 61 (61): 73-79, 2000
10 "Short-term augmentation of fluoxetine with clonazepam in the treatment of depresion: a double-blind study" 155 (155): 1339-1345, 1998
1 "주요 우울증 환자에서의 Mirtazapine의 항우울 효과" 11 (11): 126-135, 2000
2 "World Health Organization. International Statistical Classification of Diseases and Related Health Problems" -10, geneva1992.
3 "Treatment of coexisting depression and anxiety: The Depression Research in European Society(DEPRES) Survey" 5 : 9-11, 19
4 "The selective alpha2-adrenoceptor an-tagonist mirtazapine (Org 3770) enhances noradrenergic and 5-HT1A-mediated serotonergic neurotransmission" 4 (4): 29-38, 1995
5 "The pharmacology of putative early-onset antidepressant strategies." 13 (13): 57-66, 2003
6 "The efects of mirtazapine on central noradrenergic and serotonergic neurotransmision." 10 (10): 19-24, 1995
7 "The alpha2 selective adrenoceptor antagonist Org 3770 (mirtazapine, Remeron) en-hances noradrenergic and serotonergic transmission" 10 : 107-119, 195
8 "Starting SRI antidepressant therapy: its efects on tricyclic antidepressant and benzodiazepine prescribing" 164 : 509-, 1996
9 "Short-term cotherapy with clonazepam and fluoxetine sleep dis-turbance and core symptoms of depression." 61 (61): 73-79, 2000
10 "Short-term augmentation of fluoxetine with clonazepam in the treatment of depresion: a double-blind study" 155 (155): 1339-1345, 1998
11 "Onset of action of antidepressants: results of different analyses." 17 (17): 27-32, 2002
12 "Mixed anxiety-depression in a primary-care clinic" 34 : 79-84, 1995
13 "Mirtazapine compared with paroxetine in major depression" 61 (61): 656-663, 20
14 "Is antidepressant-ben-zodiazepine combination therapy clinically more useful? A meta-analytic study" 65 (65): 173-17, 2001
15 "Identification of depresed patient types in the community and their treatment needs: findings from the DEPRES II Depression Research in European Society I) survey" 14 : 153-165, 1999
16 "Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960" 56-62,
17 "Efficacy of mirtazapine in clinically relevant subgroups of depresed patients" 7 : 7-10, 198
18 "Does mirtazapine have a more rapid onset than SSRIs?" 62 (62): 358-361, 2001
19 "Care of depressed patients with anxiety symptoms." 60 (60): 23-27, 1999
20 "Benzodiazepine side-efects: from the bench to the clinic" 8 (8): 1-3, 2002
21 "Basic psychopharmacology of antidepressants Antidepressants have seven distinct mechanisms of action. J"